摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(diethylamino)ethyl pivalate | 21951-43-9

中文名称
——
中文别名
——
英文名称
2-(diethylamino)ethyl pivalate
英文别名
2-(Diethylamino)ethyl 2,2-dimethylpropanoate;2-(diethylamino)ethyl 2,2-dimethylpropanoate
2-(diethylamino)ethyl pivalate化学式
CAS
21951-43-9
化学式
C11H23NO2
mdl
——
分子量
201.309
InChiKey
DZZLVXFRRMPMQC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.3
  • 重原子数:
    14
  • 可旋转键数:
    7
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.91
  • 拓扑面积:
    29.5
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

  • 作为产物:
    描述:
    三甲基乙酰氯三乙胺potassium tetrachloroplatinate(II) 、 copper(II) choride dihydrate 、 硫酸三乙胺 作用下, 以 二氯甲烷 为溶剂, 反应 27.0h, 以88%的产率得到2-(diethylamino)ethyl pivalate
    参考文献:
    名称:
    脂肪胺的铂催化、末端选择性 C(sp3)-H 氧化
    摘要:
    本通讯描述了脂肪胺的终端选择性、Pt 催化的 C(sp(3))-H 氧化,无需定向基团。CuCl2 用作化学计量氧化剂,在 Pt 负载量低至 1 mol% 的情况下,反应以高产率进行。这些转化是在硫酸存在下进行的,硫酸与胺底物原位反应形成铵盐。我们建议胺的质子化至少起到三个重要作用:(i)它使底物可溶于水性反应介质中;(ii) 它限制胺氮与 Pt 或 Cu 的结合;(iii) 它以电子方式使靠近氮中心的 CH 键失活。我们证明该策略对各种伯胺、仲胺和叔胺的终端选择性 C(sp(3))-H 氧化是有效的。
    DOI:
    10.1021/jacs.5b09099
点击查看最新优质反应信息

文献信息

  • 3-CARBAMOYL-2-PYRIDONE DERIVATIVES
    申请人:ISHIZUKA Natsuki
    公开号:US20120208813A1
    公开(公告)日:2012-08-16
    The present invention provides compounds having an agonistic activity to the cannabinoid receptor, which is represented by the formula (I): wherein R 1 , R 2 , R 3 , R 4 , and G are defined as herein, a pharmaceutically acceptable salt or a solvate thereof, and pharmaceutical compositions, atopic dermatitis treating agents, and anti-pruritus agents, especially anti-pruritus agents for oral used and for external application, which each contains the said compound as an active ingredient.
    本发明提供了具有激动大麻素受体的活性的化合物,该受体由公式(I)表示:其中R1、R2、R3、R4和G如本文所定义,其药学上可接受的盐或溶剂,以及制备该化合物为活性成分的药物组合物、治疗特应性皮炎的药剂和抗瘙痒剂,尤其是用于口服和外用的抗瘙痒剂。
  • ION COMPLEX MATERIAL HAVING ABILITY TO INHIBIT ADHESION OF BIOLOGICAL MATERIALS, AND METHOD FOR PRODUCING SAME
    申请人:Nissan Chemical Industries, Ltd.
    公开号:EP3231825A1
    公开(公告)日:2017-10-18
    The present invention provides a copolymer or the like obtained by polymerizing a monomer mixture including at least compounds represented by formulas (A), (B), and (C) (in the formulas, Ta, Tb, Tc, Ua1, Ua2, Ub1, Ub2, Ub3, Qa, Qb, Qc, Ra, Rb, Rc, An-, and m are as defined in the description and claims). The copolymer of the present invention can be utilized as an ion complex material having an exceptional ability to inhibit adhesion of biological materials.
    本发明提供了一种共聚物或类似物,该共聚物通过聚合至少包括式(A)、(B)和(C)所代表化合物的单体混合物而获得(式中,Ta、Tb、Tc、Ua1、Ua2、Ub1、Ub2、Ub3、Qa、Qb、Qc、Ra、Rb、Rc、An- 和 m 如说明和权利要求中所定义)。本发明的共聚物可用作离子络合材料,具有抑制生物材料粘附的特殊能力。
  • 3-CARBAMOYL-2-PYRIDONE DERIVATIVE
    申请人:SHIONOGI & CO., LTD.
    公开号:EP1806342B1
    公开(公告)日:2013-04-17
  • CELL CULTURE VESSEL
    申请人:NISSAN CHEMICAL CORPORATION
    公开号:US20190233792A1
    公开(公告)日:2019-08-01
    The present invention provides a cell culture vessel having a surface coated with a copolymer including a repeating unit containing a group represented by the following formula (a), a repeating unit containing a group represented by the following formula (b), and a repeating unit containing a group represented by the following formula (c) (wherein U a1 , U a2 , U b1 , U b2 , U b3 , R c and An − are as defined in the description and the claims). The invention also provides a method for producing such cell culture vessels, and a method for producing a cell aggregate using the vessel.
  • CELL CULTURE CONTAINER CAPABLE OF LONG-TERM CULTURE AND METHOD FOR MANUFACTURING SAME
    申请人:NISSAN CHEMICAL CORPORATION
    公开号:US20200369999A1
    公开(公告)日:2020-11-26
    The present invention provides a cell culture container for long term non-adherent cell culture which comprises having a coating containing a copolymer which is a copolymer having a recurring unit which contains a group represented by the following formula (a), a recurring unit which contains a group represented by the following formula (b), and a recurring unit which contains a group represented by the following formula (c), and a molar ratio of the recurring unit which contains a group represented by the formula (c) being 1 to 50 mol % based on the whole copolymer, provided with at least a part of a surface thereof [wherein, U a1 , U a2 , U b1 , U b2 and U b3 , R c , and An − are as defined in the specification and Claims.]
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物